Stevanato Group (NYSE:STVN) Share Price Breaks Below 200-Day Moving Average After Earnings Miss

Stevanato Group S.p.A. (NYSE:STVN) crossed below its 200-day moving average during trading on Tuesday following a dissappointing earnings announcement. The stock has a 200-day moving average of €18.11 and traded as low as €13.03. Stevanato Group shares last traded at €14.19, with a volume of 4,785,200 shares.

The company reported €0.16 earnings per share (EPS) for the quarter, missing the consensus estimate of €0.17 by (€0.01). The business had revenue of €326.06 million during the quarter. Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%.

Stevanato Group News Roundup

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Third-quarter revenue rose 8% year over year to €326.1 million, and adjusted earnings of $0.18 per share topped the Zacks consensus estimate of $0.17. The results point to continued growth in the business despite concerns about future demand. Stevanato Group Q3 results
• Negative Sentiment: Management expects only low-single-digit growth in 2027, citing lower GLP-1 syringe volumes associated with one customer. The subdued forecast raised concerns about growth concentration and near-term demand, overshadowing the quarter’s revenue growth. 2027 outlook and GLP-1 syringe volumes
• Neutral Sentiment: A law firm announced an investigation into whether Stevanato’s investor disclosures complied with U.S. securities laws. The notice is an allegation of a pending review, not a finding of wrongdoing, but could add uncertainty for investors. Investigation notice

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on the company. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Deutsche Bank Aktiengesellschaft started coverage on Stevanato Group in a research report on Wednesday, October 7th. They set a “hold” rating on the stock. Finally, UBS Group assumed coverage on Stevanato Group in a report on Wednesday, September 9th. They set a “neutral” rating and a $23.00 price target for the company. Two analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, Stevanato Group presently has a consensus rating of “Moderate Buy”.

Insider Activity at Stevanato Group

In related news, Director Luciano Santel sold 2,023 shares of the business’s stock in a transaction dated Friday, August 7th. The stock was sold at an average price of €20.09, for a total value of €40,642.07. Following the sale, the director directly owned 4,739 shares in the company, valued at approximately €95,206.51. The trade was a 29.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Marco Dal Lago sold 4,209 shares of the business’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of €20.09, for a total transaction of €84,558.81. Following the completion of the sale, the chief financial officer directly owned 81,144 shares in the company, valued at approximately €1,630,182.96. This trade represents a 4.93% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 21,926 shares of company stock valued at $459,738 in the last three months.

Institutional Trading of Stevanato Group

A number of institutional investors have recently added to or reduced their stakes in STVN. State of Wyoming purchased a new position in shares of Stevanato Group during the 3rd quarter valued at about $75,000. Schwartz Investment Counsel Inc. boosted its stake in Stevanato Group by 15.0% in the third quarter. Schwartz Investment Counsel Inc. now owns 661,136 shares of the company’s stock worth $13,871,000 after buying an additional 86,385 shares in the last quarter. PineStone Asset Management Inc. boosted its stake in Stevanato Group by 8.4% in the third quarter. PineStone Asset Management Inc. now owns 41,335 shares of the company’s stock worth $867,000 after buying an additional 3,200 shares in the last quarter. Fenimore Asset Management Inc bought a new position in Stevanato Group during the third quarter valued at approximately $12,212,000. Finally, Integrated Wealth Concepts LLC bought a new position in Stevanato Group during the second quarter valued at approximately $59,000.

Stevanato Group Price Performance

The firm has a market capitalization of $4.30 billion, a P/E ratio of 25.34, a PEG ratio of 1.62 and a beta of 0.80. The business’s 50-day simple moving average is €20.35 and its 200 day simple moving average is €18.11. The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.21.

About Stevanato Group

Stevanato Group S.p.A. is an Italy-based provider of drug-containment and drug-delivery solutions for the pharmaceutical, biotechnology and healthcare industries. Founded in 1949, the company has developed from a glass-packaging manufacturer into an integrated supplier serving customers throughout the global pharmaceutical supply chain.

The company manufactures primary packaging products, including glass vials, syringes, cartridges and ampoules, as well as components and systems used to contain and administer injectable medicines.